Elevated Clinical

Neurodegenerative disease trials can be difficult to enroll. From Alzheimer's and Parkinson's to ALS and Multiple Sclerosis, recruitment timelines are stretching longer, costs are skyrocketing, and promising treatments are being delayed or abandoned. Traditional approaches to trial recruitment are falling short across the neurology space, leaving pharmaceutical companies frustrated and patients waiting for breakthroughs. The True Cost of Delayed Recruitment - Every day your neurodegenerative disease trial falls behind schedule, you're losing $100,000 to upwards of $1M. But it's not just about money. Each day delay means: - Competitors could beat you to market in a rapidly evolving field - Investors lose confidence in your program - Most importantly, patients suffering from debilitating neurological conditions lose hope The average neurodegenerative disease trial takes at least 18-24 months just to recruit patients. Can your company afford that kind of delay in this competitive landscape? Can patients with progressive conditions wait that long? The Elevated Clinical Difference Elevated Clinical offers a unique blend of deep scientific knowledge and exceptional relationship-building skills: Our team, led by a neuroscience Ph.D., stays at the forefront of neurodegenerative disease research. We speak the language of your investigators, igniting their scientific curiosity about your trial. We don't just communicate - we connect. Our ability to build strong, trust-based relationships with sites and investigators sets us apart. We craft personalized approaches for each site, recognizing that every investigator and team is unique. We translate complex scientific concepts into compelling narratives that motivate sites and accelerate recruitment. We've cut recruitment timelines by 6+ months in challenging neurodegenerative disease trials, saving our clients millions.